Literature DB >> 10531248

Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity.

S Garg1, V Bal, S Rath, A George.   

Abstract

We have analyzed oral tolerance of microbial antigens in an experimental model in which mice are treated orally with a single small dose of soluble antigen and challenged systemically with the antigen in complete Freund's adjuvant. We found that, while oral administration of sonicated extracts of either Leishmania major, Leishmania donovani, or Staphylococcus aureus was tolerogenic, as was administration of the nominal antigen ovalbumin or conalbumin, oral administration of Escherichia coli or Salmonella typhimurium sonicated extract was not. Since E. coli is an enteric commensal that colonizes the intestine soon after birth, these data suggested that lack of demonstrable oral tolerance may be related to the frequency of oral exposure to an antigen. In support of this, we found that multiple oral doses of ovalbumin or S. aureus or L. donovani antigens did not increase systemic hyporesponsiveness beyond that achieved with a single oral dose. We have also tested the ability of mice fed with sonicates of the tolerogenic S. aureus or the nontolerogenic S. typhimurium to clear a subsequent systemic infection with the homologous bacteria and found that, while clearance of S. aureus was unaffected by prior feeding, clearance of S. typhimurium was actually enhanced. The data suggest that frequent oral antigenic exposure may eventually lead to induction of systemic immunity in tolerant mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531248      PMCID: PMC96974     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.

Authors:  P Pierre; O Denis; H Bazin; E Mbongolo Mbella; J P Vaerman
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

2.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

3.  Generation of gamma interferon responses in murine Peyer's patches following oral immunization.

Authors:  A George
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.

Authors:  Z Y Wang; J Qiao; A Melms; H Link
Journal:  Cell Immunol       Date:  1993-12       Impact factor: 4.868

5.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Effects of oral administration of type II collagen on rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius-Trentham; E J Orav; D Combitchi; C Lorenzo; K L Sewell; D A Hafler; H L Weiner
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

7.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

8.  Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

Authors:  J D Clements; N M Hartzog; F L Lyon
Journal:  Vaccine       Date:  1988-06       Impact factor: 3.641

9.  Lack of oral tolerance in C3H/HeJ mice.

Authors:  H Kiyono; J R McGhee; M J Wannemuehler; S M Michalek
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

10.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  5 in total

1.  Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Cell Prolif       Date:  2009-08-17       Impact factor: 6.831

2.  Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius.

Authors:  Ann M O'Hara; Padraig O'Regan; Aine Fanning; Caitlin O'Mahony; John Macsharry; Anne Lyons; John Bienenstock; Liam O'Mahony; Fergus Shanahan
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

3.  A role for intestinal alkaline phosphatase in the maintenance of local gut immunity.

Authors:  Kathryn T Chen; Madhu S Malo; Laura Kline Beasley-Topliffe; Klaas Poelstra; Jose Luis Millan; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

4.  Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization.

Authors:  Neetha Parameswaran; Devadoss John Samuvel; Ramesh Kumar; Sangeeta Thatai; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

5.  Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC).

Authors:  S Resta-Lenert; K E Barrett
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.